Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Peptinnovate Ltd logo — company profile

Peptinnovate Ltd

Founded 2011 2-10 employees Venture round Total: $4.01M Health and Wellness, Pharmaceutical

General Information

Company Name Peptinnovate Ltd
Founded Year 2011
Employees 2-10
Industries Health and Wellness, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Peptinnovate Ltd. To contact Peptinnovate Ltd, visit peptinnovate.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Peptinnovate Ltd compare?

A PDF of Peptinnovate Ltd and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Peptinnovate Ltd soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Peptinnovate Ltd

Peptinnovate Ltd, founded in 2011, is a pharmaceutical company that focuses on researching and developing innovative new therapies to address immuno-inflammatory diseases such as asthma, atopic dermatitis, and inflammatory bowel disease. These diseases are characterized by chronic inflammation, which, if left uncontrolled, can lead to organ damage and loss of function, resulting in increased morbidity and mortality for a large portion of the population. The company aims to significantly advance the control and management of moderate to severe chronic inflammatory diseases, with the potential for disease modification and remission through their drug development efforts. In July 2018, Peptinnovate Ltd received a £217.94K investment in a Venture Round, with 24Haymarket as the investor. The company is now moving into the exciting phase of clinical development to prove the safety and efficacy of their products. With a focus on addressing critical unmet medical needs, Peptinnovate Ltd is poised to make a substantial impact in the pharmaceutical industry by providing novel treatment options for immuno-inflammatory diseases.

Business keywords: Immunology, Inflammatory diseases, Drug development, Therapeutics, Clinical research, Safety, Efficacy, Chronic inflammation, Therapy development, Disease modification, Remission, Clinical trials, Pharmaceuticals, Healthcare innovation

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round £217.94K 1
24Haymarket
24Haymarket
01 Jul 2018
Venture Round £1.09M 1
24Haymarket
24Haymarket
01 Mar 2018
Series A £2.70M 2
Fund Twenty8, NCL Technology Ventures
17 Jun 2017

Peptinnovate Ltd Alternatives & Competitors

View All Alternatives
Peptinnovate Ltd vs
InflaRx
InflaRx Germany

Controlling Inflammation - developing drugs to treat life threatening and chronic inflammatory disea...

Post-IPO Equity
46 employees
Health Care, Health and Wellness
Peptinnovate Ltd vs
Resolvyx Pharmaceuticals
Resolvyx Pharmaceuticals

Crafting the future of medicine by harnessing the body’s natural ability to resolve inflammation nat...

Venture round
11-50 employees
Biotechnology, Health and Wellness
Peptinnovate Ltd vs
Alvine Pharmaceuticals
Alvine Pharmaceuticals

Pioneering solutions for autoimmune and gastrointestinal health with a promising treatment for celia...

Debt Financing
1 employees
Biotechnology, Health and Wellness
View all alternatives

FAQ About Peptinnovate Ltd

Immuno-inflammatory diseases, including asthma, atopic dermatitis and inflammatory bowel disease, result from a poorly controlled or overactive immune response. Affecting a large proportion of the population these diseases are characterised by an increase in chronic inflammation which, if left unche...
Peptinnovate Ltd was founded in 2011.
Peptinnovate Ltd operates in Health and Wellness and Pharmaceutical. Its work centres on Immunology, Inflammatory diseases, Drug development and Therapeutics.
Peptinnovate Ltd has approximately 2-10 employees.
Peptinnovate Ltd has completed 3 funding rounds, raising a total of $4.01M. The latest funding stage is Venture round.
Top alternatives and competitors to Peptinnovate Ltd include InflaRx, Resolvyx Pharmaceuticals, Alvine Pharmaceuticals, Apellis Pharmaceuticals, Crinetics Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Peptinnovate Ltd and InflaRx are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Peptinnovate Ltd, https://bouncewatch.com/company/peptinnovate, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes